QIM
ALXN
Quantitative Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-54,273
| Closed | -$6.21M | – | 644 |
|
2020
Q3 | $6.21M | Buy |
54,273
+33,515
| +161% | +$3.83M | 0.54% | 41 |
|
2020
Q2 | $2.33M | Buy |
+20,758
| New | +$2.33M | 0.24% | 100 |
|
2020
Q1 | – | Sell |
-10,320
| Closed | -$1.12M | – | 892 |
|
2019
Q4 | $1.12M | Buy |
+10,320
| New | +$1.12M | 0.03% | 427 |
|
2019
Q3 | – | Sell |
-21,262
| Closed | -$2.78M | – | 820 |
|
2019
Q2 | $2.78M | Buy |
21,262
+13,262
| +166% | +$1.74M | 0.11% | 229 |
|
2019
Q1 | $1.08M | Buy |
+8,000
| New | +$1.08M | 0.06% | 360 |
|
2018
Q4 | – | Sell |
-9,000
| Closed | -$1.25M | – | 876 |
|
2018
Q3 | $1.25M | Buy |
+9,000
| New | +$1.25M | 0.04% | 265 |
|
2017
Q4 | – | Sell |
-34,300
| Closed | -$4.81M | – | 922 |
|
2017
Q3 | $4.81M | Buy |
+34,300
| New | +$4.81M | 0.05% | 338 |
|
2017
Q1 | – | Sell |
-5,900
| Closed | -$721K | – | 978 |
|
2016
Q4 | $721K | Sell |
5,900
-10,000
| -63% | -$1.22M | 0.02% | 651 |
|
2016
Q3 | $1.95M | Buy |
+15,900
| New | +$1.95M | 0.06% | 317 |
|
2015
Q4 | – | Sell |
-35,500
| Closed | -$5.55M | – | 898 |
|
2015
Q3 | $5.55M | Sell |
35,500
-33,999
| -49% | -$5.32M | 0.42% | 55 |
|
2015
Q2 | $12.6M | Buy |
+69,499
| New | +$12.6M | 1.89% | 9 |
|
2015
Q1 | – | Sell |
-4,400
| Closed | -$814K | – | 772 |
|
2014
Q4 | $814K | Sell |
4,400
-1,200
| -21% | -$222K | 0.13% | 171 |
|
2014
Q3 | $928K | Buy |
+5,600
| New | +$928K | 0.18% | 103 |
|
2014
Q2 | – | Sell |
-11,500
| Closed | -$1.75M | – | 693 |
|
2014
Q1 | $1.75M | Buy |
11,500
+3,000
| +35% | +$456K | 0.08% | 164 |
|
2013
Q4 | $1.13M | Buy |
+8,500
| New | +$1.13M | 0.11% | 181 |
|